MYO News and Press, Myomo Inc. From 01/17/24

2024-01-17 09:59:55 ET More on Myomo Myomo: Navigating Market Pressures And CMS Reclassification Myomo: Market Severely Undervaluing Opportunity Stocks To Watch: Nvidia, Lowe's, Deere And Best Buy Line Up To Report ELAB, KIND and RLX among pre-market losers ...

2024-01-17 09:00:32 ET Losers: DatChat DATS -32% plans to sell shares through public offering . Acurx Pharmaceuticals ( NASDAQ: ACXP ) -24% announces positive comparative Microbiology and Microbiome data for Ibezapolstat from phase 2b clinical trial in CDI ...

Myomo, Inc. (NYSE American: MYO) (" Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has entered into securities purchase agreements with certain ne...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced preliminary revenue and operating metrics fo...

2023-12-29 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Healthcare and utilities could perform better in 2024 - analyst Arcus, Bristol-Myers, ...

2023-12-21 10:00:01 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector For further details see: Cassava Sciences, Myomo among healthcare movers

2023-12-21 08:16:36 ET Losers: Polished.com ( POL ) -36% . Dune Acquisition Corporation ( DUNE ) -17% . Panbela Therapeutics ( PBLA ) -10% . Applied UV ( AUVI ) -9% . Tantech Holdings Ltd ( TANH ) -9% . Longeveron ( LGVN ...

2023-12-18 05:00:28 ET Summary Myomo faces opportunities and challenges post-CMS reclassification of MyoPro, affecting pricing and market reach. The reclassification of MyoPro as a brace could potentially lead to a broader market reach, but reimbursement rates remain uncertain. ...

2023-12-15 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Myomo, Aileron...

2023-12-12 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As you may already suspect, there are not a lot of stocks up 1000% year-to-date, but several stocks trading on major exchanges are up 1000% from their lows set earlier in the calendar year. The...